IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1167/iovs.08-3165 on January 31, 2009
(Investigative Ophthalmology and Visual Science. 2009;50:3048-3055.)
© 2009 by The Association for Research in Vision and Ophthalmology, Inc.
doi:10.1167/iovs.08-3165

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
iovs.08-3165v1
50/7/3048    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Damato, B.
Right arrow Articles by Coupland, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Damato, B.
Right arrow Articles by Coupland, S. E.

Multiplex Ligation-Dependent Probe Amplification of Uveal Melanoma: Correlation with Metastatic Death

Bertil Damato,1 Justyna Dopierala,2 Annelies Klaasen,3 Marcory van Dijk,4 Julie Sibbring,5 and Sarah E. Coupland2

1From the Liverpool Ocular Oncology Centre, St. Paul’s Eye Clinic, Royal Liverpool University Hospital, Liverpool, United Kingdom; the 2Department of Pathology, University of Liverpool, Liverpool, United Kingdom; the 3Department of Pathology, University Medical Centre Nijmegen, Nijmegen, The Netherlands; the 4Department of Pathology, University Hospital Groningen, Groningen, The Netherlands; and the 5Molecular Genetic Department, Liverpool Women’s Hospital, Liverpool, United Kingdom.

PURPOSE. To evaluate multiplex ligation-dependent probe amplification (MLPA) of uveal melanoma as a predictive tool for metastatic death.

METHODS. Uveal melanoma specimens of 73 patients treated between 1998 and 2000 were included. DNA samples were analyzed with MLPA evaluating 31 loci on chromosomes 1, 3, 6 and 8, and the results were correlated with metastatic death.

RESULTS. The patients (27 women; 46 men) had a median age of 60.6 years and a median follow-up of 6.2 years. Metastatic death occurred in 28 patients, correlating most strongly with chromosome 3 losses and gains on 8q (Cox univariate analysis, P < 0.001). Chromosome 6, region p25, gains correlated with good survival (Cox univariate analysis, P = 0.003). Prediction of metastatic death was improved by considering equivocal chromosome 3 losses as abnormal and by taking account of multiple risk factors, such as 8q gains, tumor diameter, and histologic features indicative of high-grade malignancy.

CONCLUSIONS. MLPA analysis of uveal melanoma predicts metastatic death if statistically insignificant losses of chromosome 3 are considered together with gains in 8q as well as clinical stage and histologic grade of malignancy.





This article has been cited by other articles:


Home page
IOVSHome page
S. E. Coupland, H. Vorum, N. Mandal, H. Kalirai, B. Honore, S. F. Urbak, S. L. Lake, J. Dopierala, and B. Damato
Proteomics of Uveal Melanomas Suggests HSP-27 as a Possible Surrogate Marker of Chromosome 3 Loss
Invest. Ophthalmol. Vis. Sci., January 1, 2010; 51(1): 12 - 20.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
B. Damato and S. E. Coupland
Translating Uveal Melanoma Cytogenetics Into Clinical Care
Arch Ophthalmol, April 1, 2009; 127(4): 423 - 429.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the Association for Research in Vision and Ophthalmology